StonvexLoading…
StonvexStonvexStonvexCore line items from XAIR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $5.77M | $3.58M | $1.76M | $3.71M |
Operating Income | $-21.87M | $-15.28M | $-7.62M | $-44.54M |
Net Income | $-22.97M | $-15.63M | $-7.69M | $-46.63M |
EPS (Diluted) | $-3.44 | $-2.75 | $-1.53 | $-0.69 |
Total Assets | $36.77M | $30.96M | $28.11M | $30.06M |
Total Liabilities | $28.49M | $17.87M | $17.71M | $15.72M |
Cash & Equivalents | $6.64M | $9.70M | $4.98M | $4.67M |
Free Cash Flow OCF − CapEx | $-13.68M | $-9.42M | $-4.72M | $-44.10M |
Shares Outstanding | 8.40M | 8.01M | 4.69M | 4.13M |